LAVA Therapeutics N.V.

Contributing Author

Recent Articles by LAVA Therapeutics N.V.

Nov-13	LAVA Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist from Nasdaq GlobeNewswire
Nov-10	LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline GlobeNewswire
Sep-30	LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025 GlobeNewswire
Aug-13	LAVA Reports Second Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire
May-14	LAVA Reports First Quarter 2025 Financial Results, Provides Business Update GlobeNewswire